Market Overview

The Global Tuberculosis Diagnostics Market was valued at USD 2,759.8 million in 2023 and is expected to reach USD 4,203.4 million by 2031 while growing at a CAGR of 5.4% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global tuberculosis diagnostics market growth. TB diagnostics involve detecting and diagnosing Mycobacterium tuberculosis infection, a contagious bacterial disease primarily affecting the lungs but also other body parts. Early and accurate diagnosis is vital for prompt treatment and preventing spread.

The high prevalence of tuberculosis, along with innovations in diagnostic technologies such as nucleic acid amplification tests (NAATs), rapid molecular assays, and point-of-care tests, propels the tuberculosis diagnostics market forward. Nonetheless, cost constraints and the complexity of diagnosis could hinder market growth.

Furthermore, the global tuberculosis diagnostics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Diagnostic Test Type Analysis

The Global Tuberculosis Diagnostics Market is segmented among Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Drug Resistance Test, and Other Diagnostic Test Types, based on Diagnostic Test Type. In 2023, Nucleic Acid Testing accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End User Analysis

The Global Tuberculosis Diagnostics Market is segmented among Hospital/Clinics, Diagnostics/Research Laboratory, and Other End Users, based on Type. In 2023, Diagnostics/Research Laboratory accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Tuberculosis Diagnostics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, Asia Pacific dominated the market with the highest market share, while North America is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbott Laboratories, Becton, Dickinson and Company, BioMerieux SA, Cepheid, F. Hoffmann-La Roche AG, Hain Lifescience GmbH, Hologic Corporation, Qiagen, AdvaCare Pharma, and Thermo Fisher Scientific Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Tuberculosis Diagnostics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Tuberculosis Diagnostics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Tuberculosis Diagnostics Market Segmentation, By Diagnostic Test Type

• Global Tuberculosis Diagnostics Market Share Analysis, By Diagnostic Test Type

• Global Tuberculosis Diagnostics Market Growth Analysis, By Diagnostic Test Type

• Global Tuberculosis Diagnostics Market Trends, By Diagnostic Test Type

o Radiographic Test

o Laboratory Test

o Nucleic Acid Testing

o Cytokine Detection Test

o Drug Resistance Test

o Other Diagnostic Test Types

6. Global Tuberculosis Diagnostics Market Segmentation, By End User

• Global Tuberculosis Diagnostics Market Share Analysis, By End User

• Global Tuberculosis Diagnostics Market Growth Analysis, By End User

• Global Tuberculosis Diagnostics Market Trends, By End User

o Hospital/Clinics

o Diagnostics/Research Laboratory

o Other End Users

7. Global Tuberculosis Diagnostics Market Segmentation, By Region

• Global Tuberculosis Diagnostics Market Share Analysis, By Region

• Global Tuberculosis Diagnostics Market Growth Analysis, By Region

• Global Tuberculosis Diagnostics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Abbott Laboratories*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Becton, Dickinson and Company

• BioMerieux SA

• Cepheid

• F. Hoffmann-La Roche AG

• Hain Lifescience GmbH

• Hologic Corporation

• Qiagen

• AdvaCare Pharma

• Thermo Fisher Scientific Inc.

*Similar analysis will be provided for each company listed above.